Remission and low disease activity (LDA) prevent damage accrual in systemic lupus erythematosus patients. Results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

Manuel Ugarte-Gil, JG Hanly, MB Urowitz, Caroline Gordon, SC Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, S Bernatsky, A. E Clarke, D. J Wallace, David Isenberg, A Rahman, JT Merrill, PR Fortin, DD Gladman, I. N Bruce, M. A Petri, Ellen Ginzler, MA Dooley, R Ramsey GoldmanS Manzi, Andreas Jonsen, Ronald van Vollenhoven, Cynthia Aranow, M Mackay, Guillermo Ruiz-Irastorza, S. S Lim, M Inanc, K. C Kalunian, S. Jacobsen, C Peschken, Diane L Kamen, Anca D Askanase, Bernado Pons-Estel, GS Alarcón

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Publication statusAccepted/In press - 13 Jul 2022

Bibliographical note

Not yet published as of 27/07/2022.

Fingerprint

Dive into the research topics of 'Remission and low disease activity (LDA) prevent damage accrual in systemic lupus erythematosus patients. Results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort'. Together they form a unique fingerprint.

Cite this